Morgan Stanley’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$58M Sell
1,342,378
-156,241
-10% -$6.75M ﹤0.01% 1790
2025
Q1
$51.8M Buy
1,498,619
+247,002
+20% +$8.54M ﹤0.01% 1788
2024
Q4
$34.3M Sell
1,251,617
-124,125
-9% -$3.41M ﹤0.01% 2200
2024
Q3
$35M Sell
1,375,742
-53,267
-4% -$1.36M ﹤0.01% 2208
2024
Q2
$36.2M Buy
1,429,009
+247,115
+21% +$6.26M ﹤0.01% 2047
2024
Q1
$36.5M Sell
1,181,894
-2,137,670
-64% -$66.1M ﹤0.01% 2060
2023
Q4
$134M Buy
3,319,564
+1,871,504
+129% +$75.6M 0.01% 1445
2023
Q3
$38.2M Buy
1,448,060
+894,647
+162% +$23.6M ﹤0.01% 1831
2023
Q2
$9.52M Sell
553,413
-361,378
-40% -$6.22M ﹤0.01% 3219
2023
Q1
$15.2M Sell
914,791
-141,046
-13% -$2.34M ﹤0.01% 2718
2022
Q4
$8.05M Buy
1,055,837
+32,023
+3% +$244K ﹤0.01% 3285
2022
Q3
$10.2M Sell
1,023,814
-310,646
-23% -$3.09M ﹤0.01% 2969
2022
Q2
$12.1M Buy
1,334,460
+177,522
+15% +$1.61M ﹤0.01% 2865
2022
Q1
$11.7M Buy
1,156,938
+762,451
+193% +$7.74M ﹤0.01% 2719
2021
Q4
$6.58M Buy
394,487
+174,978
+80% +$2.92M ﹤0.01% 3427
2021
Q3
$10.3M Sell
219,509
-167,909
-43% -$7.87M ﹤0.01% 2858
2021
Q2
$23.6M Sell
387,418
-56,084
-13% -$3.42M ﹤0.01% 1975
2021
Q1
$27.3M Buy
443,502
+369,317
+498% +$22.8M ﹤0.01% 1638
2020
Q4
$5.28M Buy
74,185
+50,494
+213% +$3.59M ﹤0.01% 3198
2020
Q3
$889K Sell
23,691
-35,826
-60% -$1.34M ﹤0.01% 4293
2020
Q2
$1.94M Buy
59,517
+37,102
+166% +$1.21M ﹤0.01% 3629
2020
Q1
$650K Sell
22,415
-15,855
-41% -$460K ﹤0.01% 4233
2019
Q4
$1.34M Buy
38,270
+29,682
+346% +$1.04M ﹤0.01% 4331
2019
Q3
$185K Sell
8,588
-21,112
-71% -$455K ﹤0.01% 5169
2019
Q2
$801K Buy
+29,700
New +$801K ﹤0.01% 4349